In the last trading session, 2.74 million Alaunos Therapeutics Inc (NASDAQ:TCRT) shares changed hands as the company’s beta touched -1.69. With the company’s per share price at $2.95 changed hands at -$1.27 or -30.09% during last session, the market valuation stood at $4.72M. TCRT’s last price was a discount, traded about -516.95% off its 52-week high of $18.20. The share price had its 52-week low at $1.31, which suggests the last value was 55.59% up since then. When we look at Alaunos Therapeutics Inc’s average trading volume, we note the 10-day average is 2.83 million shares, with the 3-month average coming to 430.46K.
Analysts gave the Alaunos Therapeutics Inc (TCRT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TCRT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Alaunos Therapeutics Inc’s EPS for the current quarter is expected to be 0.
Alaunos Therapeutics Inc (NASDAQ:TCRT) trade information
Instantly TCRT was in red as seen at the end of in last trading. With action 102.05%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 54.86%, with the 5-day performance at 102.05% in the green. However, in the 30-day time frame, Alaunos Therapeutics Inc (NASDAQ:TCRT) is 96.67% up. Looking at the short shares, we see there were 51732.0 shares sold at short interest cover period of 5.18 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 51.16%.
TCRT Dividends
Alaunos Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Mar-31.
Alaunos Therapeutics Inc (NASDAQ:TCRT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.11% of Alaunos Therapeutics Inc shares while 4.51% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.25%. There are 4.51% institutions holding the Alaunos Therapeutics Inc stock share, with MSD PARTNERS, L.P. the top institutional holder. As of 2024-06-30, the company held 6.3082% of the shares, roughly 1.01 million TCRT shares worth $0.71 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 1.3892% or 0.22 million shares worth $0.16 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 20.47 shares estimated at $60389.0 under it, the former controlled 1.28% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.54% of the shares, roughly 8.7 shares worth around $25665.0.
